![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 17168 |
FusionGeneSummary for IGF2R_SYTL3 |
![]() |
Fusion gene information | Fusion gene name: IGF2R_SYTL3 | Fusion gene ID: 17168 | Hgene | Tgene | Gene symbol | IGF2R | SYTL3 | Gene ID | 3482 | 94120 |
Gene name | insulin like growth factor 2 receptor | synaptotagmin like 3 | |
Synonyms | CD222|CI-M6PR|CIMPR|M6P-R|M6P/IGF2R|MPR 300|MPR1|MPR300|MPRI | SLP3 | |
Cytomap | 6q25.3 | 6q25.3 | |
Type of gene | protein-coding | protein-coding | |
Description | cation-independent mannose-6-phosphate receptor300 kDa mannose 6-phosphate receptorCI Man-6-P receptorIGF-II receptorM6P/IGF2 receptorinsulin-like growth factor II receptor | synaptotagmin-like protein 3exophilin-6 | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | P11717 | Q4VX76 | |
Ensembl transtripts involved in fusion gene | ENST00000356956, ENST00000475584, | ENST00000360448, ENST00000297239, ENST00000367081, ENST00000469735, | |
Fusion gene scores | * DoF score | 7 X 6 X 6=252 | 3 X 3 X 3=27 |
# samples | 6 | 3 | |
** MAII score | log2(6/252*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: IGF2R [Title/Abstract] AND SYTL3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LUSC | TCGA-66-2800-01A | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000356956 | ENST00000360448 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
In-frame | ENST00000356956 | ENST00000297239 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
5CDS-intron | ENST00000356956 | ENST00000367081 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
5CDS-intron | ENST00000356956 | ENST00000469735 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
intron-3CDS | ENST00000475584 | ENST00000360448 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
intron-3CDS | ENST00000475584 | ENST00000297239 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
intron-intron | ENST00000475584 | ENST00000367081 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
intron-intron | ENST00000475584 | ENST00000469735 | IGF2R | chr6 | 160390427 | + | SYTL3 | chr6 | 159129354 | + |
Top |
FusionProtFeatures for IGF2R_SYTL3 |
![]() |
Hgene | Tgene |
IGF2R | SYTL3 |
Transport of phosphorylated lysosomal enzymes from theGolgi complex and the cell surface to lysosomes. Lysosomal enzymesbearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resultingreceptor-ligand complex is transported to an acidic prelyosomalcompartment where the low pH mediates the dissociation of thecomplex. This receptor also binds IGF2. Acts as a positiveregulator of T-cell coactivation, by binding DPP4.{ECO:0000269|PubMed:10900005}. | May act as Rab effector protein and play a role invesicle trafficking. Binds phospholipids in the presence ofcalcium ions (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >SYTL3 | chr6:160390427 | chr6:159129354 | ENST00000297239 | + | 5 | 17 | 308_412 | 148 | 611 | Domain | C2 1 |
Tgene | >SYTL3 | chr6:160390427 | chr6:159129354 | ENST00000297239 | + | 5 | 17 | 467_571 | 148 | 611 | Domain | C2 2 |
Tgene | >SYTL3 | chr6:160390427 | chr6:159129354 | ENST00000360448 | + | 7 | 17 | 308_412 | 148 | 543 | Domain | C2 1 |
Tgene | >SYTL3 | chr6:160390427 | chr6:159129354 | ENST00000360448 | + | 7 | 17 | 467_571 | 148 | 543 | Domain | C2 2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 1898_1944 | 49 | 2492 | Domain | Fibronectin type-II |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 1100_1243 | 49 | 2492 | Repeat | Note=8 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 1244_1384 | 49 | 2492 | Repeat | Note=9 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 1385_1532 | 49 | 2492 | Repeat | Note=10 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 1533_1666 | 49 | 2492 | Repeat | Note=11 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 1667_1820 | 49 | 2492 | Repeat | Note=12 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 1821_2008 | 49 | 2492 | Repeat | Note=13 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 190_344 | 49 | 2492 | Repeat | Note=2 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 2009_2137 | 49 | 2492 | Repeat | Note=14 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 2165_2289 | 49 | 2492 | Repeat | Note=15 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 345_489 | 49 | 2492 | Repeat | Note=3 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 40_189 | 49 | 2492 | Repeat | Note=1 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 490_643 | 49 | 2492 | Repeat | Note=4 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 644_783 | 49 | 2492 | Repeat | Note=5 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 784_950 | 49 | 2492 | Repeat | Note=6 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 951_1099 | 49 | 2492 | Repeat | Note=7 |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 2328_2491 | 49 | 2492 | Topological domain | Cytoplasmic |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 41_2304 | 49 | 2492 | Topological domain | Lumenal |
Hgene | >IGF2R | chr6:160390427 | chr6:159129354 | ENST00000356956 | + | 1 | 48 | 2305_2327 | 49 | 2492 | Transmembrane | Helical |
Tgene | SYTL3 | chr6:160390427 | chr6:159129354 | ENST00000297239 | + | 5 | 17 | 4_123 | 148 | 611 | Domain | RabBD |
Tgene | SYTL3 | chr6:160390427 | chr6:159129354 | ENST00000360448 | + | 7 | 17 | 4_123 | 148 | 543 | Domain | RabBD |
Top |
FusionGeneSequence for IGF2R_SYTL3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_IGF2R_ENST00000356956_chr6_160390427_+_SYTL3_ENST00000360448_chr6_159129354_+_444aa MGAAAGRSPHLGPAPARRPQRSLLLLQLLLLVAAPGSTQAQAAPFPELCSKISVVPPTPPPVSESQCSRSPGRKVSAPDILKPLNQEDPK CSTNPILKQQNLPSSPAPSTIFSGGFRHGSLISIDSTCTEMGNFDNANVTGEIEFAIHYCFKTHSLEICIKACKNLAYGEEKKKKCNPYV KTYLLPDRSSQGKRKTGVQRNTVDPTFQETLKYQVAPAQLVTRQLQVSVWHLGTLARRVFLGEVIIPLATWDFEDSTTQSFRWHPLRAKA EKYEDSVPQSNGELTVRAKLVLPSRPRKLQEAQEGTDQPSLHGQLCLVVLGAKNLPVRPDGTLNSFVKGCLTLPDQQKLRLKSPVLRKQA >In-frame_IGF2R_ENST00000356956_chr6_160390427_+_SYTL3_ENST00000297239_chr6_159129354_+_512aa MGAAAGRSPHLGPAPARRPQRSLLLLQLLLLVAAPGSTQAQAAPFPELCSKISVVPPTPPPVSESQCSRSPGRLQEFGQFRGFNKSVENL FLSLATHVKKLSKSQNDMTSEKHLLATGPRQCVGQTERRSQSDTAVNVTTRKVSAPDILKPLNQEDPKCSTNPILKQQNLPSSPAPSTIF SGGFRHGSLISIDSTCTEMGNFDNANVTGEIEFAIHYCFKTHSLEICIKACKNLAYGEEKKKKCNPYVKTYLLPDRSSQGKRKTGVQRNT VDPTFQETLKYQVAPAQLVTRQLQVSVWHLGTLARRVFLGEVIIPLATWDFEDSTTQSFRWHPLRAKAEKYEDSVPQSNGELTVRAKLVL PSRPRKLQEAQEGTDQPSLHGQLCLVVLGAKNLPVRPDGTLNSFVKGCLTLPDQQKLRLKSPVLRKQACPQWKHSFVFSGVTPAQLRQSS |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_IGF2R_ENST00000356956_chr6_160390427_+_SYTL3_ENST00000360448_chr6_159129354_+_1332nt ATGGGGGCCGCCGCCGGCCGGAGCCCCCACCTGGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTG CTCGTCGCTGCCCCGGGGTCCACGCAGGCCCAGGCCGCCCCGTTCCCCGAGCTGTGCAGCAAAATTTCTGTGGTTCCTCCTACTCCACCT CCTGTCAGCGAGAGCCAGTGCAGCCGCAGTCCTGGCAGGAAGGTCAGTGCACCAGATATTCTGAAACCTCTCAATCAAGAGGATCCCAAA TGCTCTACTAACCCTATTTTGAAGCAACAGAATCTCCCATCCAGTCCGGCACCCAGTACCATATTCTCTGGAGGTTTTAGACACGGAAGT TTAATTAGCATTGACAGCACCTGTACAGAGATGGGCAATTTTGACAATGCTAATGTCACTGGAGAAATAGAATTTGCCATTCATTATTGC TTCAAAACCCATTCTTTAGAAATATGCATCAAGGCCTGTAAGAACCTTGCCTATGGAGAAGAAAAGAAGAAAAAGTGCAATCCGTATGTG AAGACCTACCTGTTGCCCGACAGATCCTCCCAGGGAAAGCGCAAGACTGGAGTCCAAAGGAACACCGTGGACCCGACCTTTCAGGAGACC TTGAAGTATCAGGTGGCCCCTGCCCAGCTGGTGACCCGGCAGCTGCAGGTCTCGGTGTGGCATCTGGGCACGCTGGCCCGGAGAGTGTTT CTTGGAGAAGTGATCATTCCTCTGGCCACGTGGGACTTTGAAGACAGCACAACACAGTCCTTCCGCTGGCATCCGCTCCGGGCCAAGGCG GAGAAATACGAAGACAGCGTTCCTCAGAGTAATGGAGAGCTCACAGTCCGGGCTAAGCTGGTTCTCCCTTCACGGCCCAGAAAACTCCAA GAGGCTCAAGAAGGGACAGATCAGCCATCACTTCATGGTCAACTTTGTTTGGTAGTGCTAGGAGCCAAGAATTTACCTGTGCGGCCAGAT GGCACCTTGAACTCATTTGTTAAGGGCTGTCTCACTCTGCCAGACCAACAAAAACTGAGACTGAAGTCGCCAGTCCTGAGGAAGCAGGCT TGCCCCCAGTGGAAACACTCATTTGTCTTCAGTGGCGTAACCCCAGCTCAGCTGAGGCAGTCAAGCTTGGAGTTAACTGTCTGGGATCAG GCCCTCTTTGGAATGAACGACCGCTTGCTTGGAGGAACCAGACTTGGTTCAAAGGGAGACACAGCTGTTGGCGGGGATGCATGCTCACTA >In-frame_IGF2R_ENST00000356956_chr6_160390427_+_SYTL3_ENST00000297239_chr6_159129354_+_1536nt ATGGGGGCCGCCGCCGGCCGGAGCCCCCACCTGGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTG CTCGTCGCTGCCCCGGGGTCCACGCAGGCCCAGGCCGCCCCGTTCCCCGAGCTGTGCAGCAAAATTTCTGTGGTTCCTCCTACTCCACCT CCTGTCAGCGAGAGCCAGTGCAGCCGCAGTCCTGGCAGGTTACAGGAATTTGGTCAGTTTAGAGGATTTAATAAGTCCGTGGAAAATTTG TTTCTGTCTCTTGCTACCCACGTGAAAAAGCTCTCCAAATCCCAGAATGATATGACTTCTGAGAAGCATCTTCTCGCCACGGGCCCCAGG CAGTGTGTGGGACAGACAGAGAGACGGAGCCAGTCTGACACTGCGGTCAACGTCACCACCAGGAAGGTCAGTGCACCAGATATTCTGAAA CCTCTCAATCAAGAGGATCCCAAATGCTCTACTAACCCTATTTTGAAGCAACAGAATCTCCCATCCAGTCCGGCACCCAGTACCATATTC TCTGGAGGTTTTAGACACGGAAGTTTAATTAGCATTGACAGCACCTGTACAGAGATGGGCAATTTTGACAATGCTAATGTCACTGGAGAA ATAGAATTTGCCATTCATTATTGCTTCAAAACCCATTCTTTAGAAATATGCATCAAGGCCTGTAAGAACCTTGCCTATGGAGAAGAAAAG AAGAAAAAGTGCAATCCGTATGTGAAGACCTACCTGTTGCCCGACAGATCCTCCCAGGGAAAGCGCAAGACTGGAGTCCAAAGGAACACC GTGGACCCGACCTTTCAGGAGACCTTGAAGTATCAGGTGGCCCCTGCCCAGCTGGTGACCCGGCAGCTGCAGGTCTCGGTGTGGCATCTG GGCACGCTGGCCCGGAGAGTGTTTCTTGGAGAAGTGATCATTCCTCTGGCCACGTGGGACTTTGAAGACAGCACAACACAGTCCTTCCGC TGGCATCCGCTCCGGGCCAAGGCGGAGAAATACGAAGACAGCGTTCCTCAGAGTAATGGAGAGCTCACAGTCCGGGCTAAGCTGGTTCTC CCTTCACGGCCCAGAAAACTCCAAGAGGCTCAAGAAGGGACAGATCAGCCATCACTTCATGGTCAACTTTGTTTGGTAGTGCTAGGAGCC AAGAATTTACCTGTGCGGCCAGATGGCACCTTGAACTCATTTGTTAAGGGCTGTCTCACTCTGCCAGACCAACAAAAACTGAGACTGAAG TCGCCAGTCCTGAGGAAGCAGGCTTGCCCCCAGTGGAAACACTCATTTGTCTTCAGTGGCGTAACCCCAGCTCAGCTGAGGCAGTCAAGC TTGGAGTTAACTGTCTGGGATCAGGCCCTCTTTGGAATGAACGACCGCTTGCTTGGAGGAACCAGACTTGGTTCAAAGGGAGACACAGCT GTTGGCGGGGATGCATGCTCACTATCGAAGCTCCAGTGGCAGAAAGTCCTTTCCAGCCCCAATCTATGGACAGACATGACTCTTGTCCTG |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_IGF2R_ENST00000356956_chr6_160390427_+_SYTL3_ENST00000360448_chr6_159129354_+_1745nt CGAGCCCAGTCGAGCCGCGCTCACCTCGGGCTCCCGCTCCGTCTCCACCTCCGCCTTTGCCCTGGCGGCGCGACCCCGTCCCGGGCGCGG CCCCCAGCAGTCGCGCGCCGTTAGCCTCGCGCCCGCCGCGCAGTCCGGGCCCGGCGCGATGGGGGCCGCCGCCGGCCGGAGCCCCCACCT GGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTGCTCGTCGCTGCCCCGGGGTCCACGCAGGCCCA GGCCGCCCCGTTCCCCGAGCTGTGCAGCAAAATTTCTGTGGTTCCTCCTACTCCACCTCCTGTCAGCGAGAGCCAGTGCAGCCGCAGTCC TGGCAGGAAGGTCAGTGCACCAGATATTCTGAAACCTCTCAATCAAGAGGATCCCAAATGCTCTACTAACCCTATTTTGAAGCAACAGAA TCTCCCATCCAGTCCGGCACCCAGTACCATATTCTCTGGAGGTTTTAGACACGGAAGTTTAATTAGCATTGACAGCACCTGTACAGAGAT GGGCAATTTTGACAATGCTAATGTCACTGGAGAAATAGAATTTGCCATTCATTATTGCTTCAAAACCCATTCTTTAGAAATATGCATCAA GGCCTGTAAGAACCTTGCCTATGGAGAAGAAAAGAAGAAAAAGTGCAATCCGTATGTGAAGACCTACCTGTTGCCCGACAGATCCTCCCA GGGAAAGCGCAAGACTGGAGTCCAAAGGAACACCGTGGACCCGACCTTTCAGGAGACCTTGAAGTATCAGGTGGCCCCTGCCCAGCTGGT GACCCGGCAGCTGCAGGTCTCGGTGTGGCATCTGGGCACGCTGGCCCGGAGAGTGTTTCTTGGAGAAGTGATCATTCCTCTGGCCACGTG GGACTTTGAAGACAGCACAACACAGTCCTTCCGCTGGCATCCGCTCCGGGCCAAGGCGGAGAAATACGAAGACAGCGTTCCTCAGAGTAA TGGAGAGCTCACAGTCCGGGCTAAGCTGGTTCTCCCTTCACGGCCCAGAAAACTCCAAGAGGCTCAAGAAGGGACAGATCAGCCATCACT TCATGGTCAACTTTGTTTGGTAGTGCTAGGAGCCAAGAATTTACCTGTGCGGCCAGATGGCACCTTGAACTCATTTGTTAAGGGCTGTCT CACTCTGCCAGACCAACAAAAACTGAGACTGAAGTCGCCAGTCCTGAGGAAGCAGGCTTGCCCCCAGTGGAAACACTCATTTGTCTTCAG TGGCGTAACCCCAGCTCAGCTGAGGCAGTCAAGCTTGGAGTTAACTGTCTGGGATCAGGCCCTCTTTGGAATGAACGACCGCTTGCTTGG AGGAACCAGACTTGGTTCAAAGGGAGACACAGCTGTTGGCGGGGATGCATGCTCACTATCGAAGCTCCAGTGGCAGAAAGTCCTTTCCAG CCCCAATCTATGGACAGACATGACTCTTGTCCTGCACTGACATGAAGGCCTCAAGGTTCCAGGTTGCAGCAGGCGTGAGGCACTGTGCGT CTGCAGAGGGGCTACGAACCAGGTGCAGGGTCCCAGCTGGAGACCCCTTTGACCTTGAGCAGTCTCCATCTGCGGCCCTGTCCCATGGCT TAACCGCCTATTGGTATCTGTGTATATTTACGTTAAACACAATTATGTTACCTAAGCCTCTGGTGGGTTATCTCCTCTTTGAGATGTAGA >In-frame_IGF2R_ENST00000356956_chr6_160390427_+_SYTL3_ENST00000297239_chr6_159129354_+_1949nt CGAGCCCAGTCGAGCCGCGCTCACCTCGGGCTCCCGCTCCGTCTCCACCTCCGCCTTTGCCCTGGCGGCGCGACCCCGTCCCGGGCGCGG CCCCCAGCAGTCGCGCGCCGTTAGCCTCGCGCCCGCCGCGCAGTCCGGGCCCGGCGCGATGGGGGCCGCCGCCGGCCGGAGCCCCCACCT GGGGCCCGCGCCCGCCCGCCGCCCGCAGCGCTCTCTGCTCCTGCTGCAGCTGCTGCTGCTCGTCGCTGCCCCGGGGTCCACGCAGGCCCA GGCCGCCCCGTTCCCCGAGCTGTGCAGCAAAATTTCTGTGGTTCCTCCTACTCCACCTCCTGTCAGCGAGAGCCAGTGCAGCCGCAGTCC TGGCAGGTTACAGGAATTTGGTCAGTTTAGAGGATTTAATAAGTCCGTGGAAAATTTGTTTCTGTCTCTTGCTACCCACGTGAAAAAGCT CTCCAAATCCCAGAATGATATGACTTCTGAGAAGCATCTTCTCGCCACGGGCCCCAGGCAGTGTGTGGGACAGACAGAGAGACGGAGCCA GTCTGACACTGCGGTCAACGTCACCACCAGGAAGGTCAGTGCACCAGATATTCTGAAACCTCTCAATCAAGAGGATCCCAAATGCTCTAC TAACCCTATTTTGAAGCAACAGAATCTCCCATCCAGTCCGGCACCCAGTACCATATTCTCTGGAGGTTTTAGACACGGAAGTTTAATTAG CATTGACAGCACCTGTACAGAGATGGGCAATTTTGACAATGCTAATGTCACTGGAGAAATAGAATTTGCCATTCATTATTGCTTCAAAAC CCATTCTTTAGAAATATGCATCAAGGCCTGTAAGAACCTTGCCTATGGAGAAGAAAAGAAGAAAAAGTGCAATCCGTATGTGAAGACCTA CCTGTTGCCCGACAGATCCTCCCAGGGAAAGCGCAAGACTGGAGTCCAAAGGAACACCGTGGACCCGACCTTTCAGGAGACCTTGAAGTA TCAGGTGGCCCCTGCCCAGCTGGTGACCCGGCAGCTGCAGGTCTCGGTGTGGCATCTGGGCACGCTGGCCCGGAGAGTGTTTCTTGGAGA AGTGATCATTCCTCTGGCCACGTGGGACTTTGAAGACAGCACAACACAGTCCTTCCGCTGGCATCCGCTCCGGGCCAAGGCGGAGAAATA CGAAGACAGCGTTCCTCAGAGTAATGGAGAGCTCACAGTCCGGGCTAAGCTGGTTCTCCCTTCACGGCCCAGAAAACTCCAAGAGGCTCA AGAAGGGACAGATCAGCCATCACTTCATGGTCAACTTTGTTTGGTAGTGCTAGGAGCCAAGAATTTACCTGTGCGGCCAGATGGCACCTT GAACTCATTTGTTAAGGGCTGTCTCACTCTGCCAGACCAACAAAAACTGAGACTGAAGTCGCCAGTCCTGAGGAAGCAGGCTTGCCCCCA GTGGAAACACTCATTTGTCTTCAGTGGCGTAACCCCAGCTCAGCTGAGGCAGTCAAGCTTGGAGTTAACTGTCTGGGATCAGGCCCTCTT TGGAATGAACGACCGCTTGCTTGGAGGAACCAGACTTGGTTCAAAGGGAGACACAGCTGTTGGCGGGGATGCATGCTCACTATCGAAGCT CCAGTGGCAGAAAGTCCTTTCCAGCCCCAATCTATGGACAGACATGACTCTTGTCCTGCACTGACATGAAGGCCTCAAGGTTCCAGGTTG CAGCAGGCGTGAGGCACTGTGCGTCTGCAGAGGGGCTACGAACCAGGTGCAGGGTCCCAGCTGGAGACCCCTTTGACCTTGAGCAGTCTC CATCTGCGGCCCTGTCCCATGGCTTAACCGCCTATTGGTATCTGTGTATATTTACGTTAAACACAATTATGTTACCTAAGCCTCTGGTGG |
Top |
FusionGenePPI for IGF2R_SYTL3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
IGF2R | CREG1, PLIN3, PLAUR, USP50, ELAVL1, MYC, SIRT7, GGA2, GGA3, GGA1, CSNK2A1, FBXO6, TM9SF4, COA7, SERINC1, TIMM10B, ATXN1, FN1, CCDC8, ABCE1, EWSR1, TMEM17, TMEM216, RAB5C, XRCC5, GTSE1, CHMP4B, CDH1, PPM1H, NCDN, TRIM25 | SYTL3 | RAB27A, RAB10, RAB27B |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for IGF2R_SYTL3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | IGF2R | P11717 | DB01277 | Mecasermin | Cation-independent mannose-6-phosphate receptor | biotech | approved|investigational |
Top |
RelatedDiseases for IGF2R_SYTL3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | IGF2R | C0024115 | Lung diseases | 2 | CTD_human |
Hgene | IGF2R | C0235833 | Congenital diaphragmatic hernia | 2 | CTD_human |
Hgene | IGF2R | C0002395 | Alzheimer's Disease | 1 | CTD_human |
Hgene | IGF2R | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | IGF2R | C0030567 | Parkinson Disease | 1 | CTD_human |
Hgene | IGF2R | C0752347 | Lewy Body Disease | 1 | CTD_human |
Hgene | IGF2R | C2239176 | Liver carcinoma | 1 | CTD_human;HPO |